Screener
Bicara Therapeutics BCAX Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Bicara Therapeutics’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033429
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders' equity: | ||
| Preferred stock $0.0001 par value, 10,000,000 shares authorized; 0 shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value, 500,000,000 and 500,000,000 shares authorized; 65,547,037 and 56,600,724 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 8 | 7 |
| Additional paid-in capital | 929,370 | 760,168 |
| Accumulated other comprehensive (loss) income | (243) | 243 |
| Accumulated deficit | (415,177) | (358,966) |
| Total stockholders' equity | 513,958 | 401,452 |
| Total liabilities and stockholders’ equity | $553,599 | $430,994 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bicara Therapeutics's retained earnings?
- Bicara Therapeutics (BCAX) reported retained earnings of -$415.18M in Q1 2026.
- How has Bicara Therapeutics's retained earnings changed year-over-year?
- Bicara Therapeutics's retained earnings decreased by 61.0% year-over-year, from -$257.86M to -$415.18M.
- What is the long-term trend for Bicara Therapeutics's retained earnings?
- Over 2 years (2023 to 2025), Bicara Therapeutics's retained earnings has grown at a 53.2% compound annual growth rate (CAGR), from -$153.02M to -$358.97M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Bicara Therapeutics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude